Main content

    Active Clinical Trials for
    Pediatric Parenteral Nutrition Associated Liver Disease (PNALD)

    Pediatric Clinical Trials Main Page

    Further protocol information can be found on the links below at

    Active Trials

    Title: Compassionate Use of Omegaven IV Fat Emulsion in Infants With Life Threatening Parenteral Nutrition-associated Liver Disease (PNALD)
    Decscription: The purpose of the study is to provide use of Omegaven in infants with life threatening Total Parenteral Nutrition (TPN) associated cholestasis when all other medical and surgical treatments/therapies have been either ineffective or not feasible in the treatment of this serious condition. This is a compassionate use protocol.
    Investigator: David A. Lee, MD
    Eligibility: Infants, 2 months to 12 months old, with a diagnosis of life threatening PNALD and who are currently admitted to the NICU
    Status: Active and open to enrollment
    Contact: David A. Lee, MD, 415-750-6842, Email: about Study PNALD

    • updated February 2014

    Back to top